about
Prodrugs of phosphonates and phosphates: crossing the membrane barrierDiscovery of 2'-α-C-Methyl-2'-β-C-fluorouridine Phosphoramidate Prodrugs as Inhibitors of Hepatitis C Virus.Synthesis of di-, tri-, and tetrasubstituted oxetanes by rhodium-catalyzed O-H insertion and C-C bond-forming cyclizationHighly regioselective lithiation of pyridines bearing an oxetane unit by n-butyllithium.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Use of 2'-spirocyclic ethers in HCV nucleoside design.
@en
Use of 2'-spirocyclic ethers in HCV nucleoside design.
@nl
type
label
Use of 2'-spirocyclic ethers in HCV nucleoside design.
@en
Use of 2'-spirocyclic ethers in HCV nucleoside design.
@nl
prefLabel
Use of 2'-spirocyclic ethers in HCV nucleoside design.
@en
Use of 2'-spirocyclic ethers in HCV nucleoside design.
@nl
P2093
P356
P1476
Use of 2'-spirocyclic ethers in HCV nucleoside design.
@en
P2093
Angela M Lam
Byoung-Kwon Chun
Christine Espiritu
Congrong Niu
Eisuke Murakami
Haiying Bao
Holly M Micolochick Steuer
Michael J Sofia
Phillip A Furman
P304
P356
10.1021/JM401224Y
P407
P577
2013-10-18T00:00:00Z